HAVAH THERAPEUTICS
Originally founded in Australia in 2006, Palo Alto-based HAVAH Therapeutics Inc. is a clinical-stage pharmaceutical company specialising in the development of novel therapeutics for the prevention of breast cancer. Breast cancer prevention is a critical, unmet global need. HAVAH's lead product candidate, T+Ai, is a proprietary breakthrough breast cancer prevention combination therapy - reducing a woman’s risk of breast cancer whilst improving their sense of wellbeing.
HAVAH THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2006-01-01
Address:
Palo Alto, California, United States
Country:
United States
Website Url:
http://www.havahtx.com
Total Employee:
1+
Status:
Active
Contact:
(650)799-4635
Email Addresses:
[email protected]
Total Funding:
1000 K AUD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Current Employees Featured
Founder
Official Site Inspections
http://www.havahtx.com
- Host name: 221.249.213.35.bc.googleusercontent.com
- IP address: 35.213.249.221
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "HAVAH Therapeutics"
HavaH Therapeutics – Developing androgen therapies …
Matt has over 20 years of life science business development, operations, and finance experience. Previously, he served as Chief Business Officer of Ashvattha Therapeutics, raising over $65 million in capital to drive the company’s …See details»
HAVAH Therapeutics - Crunchbase Company Profile & Funding
Originally founded in Australia in 2006, Palo Alto-based HAVAH Therapeutics Inc. is a clinical-stage pharmaceutical company specialising in the development of novel therapeutics for the …See details»
Quantum Leap Healthcare Collaborative Initiates Landmark Phase …
Quantum Leap Healthcare Collaborative is a 501c(3) charitable organization established in 2005 as a collaboration between medical researchers at University of California, San Francisco and …See details»
Havah Therapeutics, Inc. - Drug pipelines, Patents, Clinical
Havahtx.com. Subsidiary Company | 2006 | California, United States | < 10 | havahtx.com. Last update 19 Sep 2024. Overview. Pipeline. Deal. Translational Medicine. Profit. ... The statistics …See details»
Havah Therapeutics Announces Formation of Clinical Advisory
Oct 24, 2024 Additional background information on the CAB members can be found on the company’s website: www.havahtx.com About RECAST DCIS Havah Therapeutics is currently …See details»
Havah Therapeutics to Present Real World Data at the RiseUp for …
BOULDER, Colo., October 30, 2024--Havah Therapeutics, a clinical stage biopharmaceutical company developing innovative, proprietary hormonal implant therapies for prevention and …See details»
HavaH Therapeutics - Overview, News & Similar companies
Oct 29, 2023 HavaH Therapeutics contact info: Phone number: (650) 799-4635 Website: www.havahtx.com What does HavaH Therapeutics do? HavaH Therapeutics is developing …See details»
HAVAH Therapeutics - Craft
HAVAH Therapeutics is a women’s hormonal health biopharmaceutical company. It develops hormonal therapies to help women with breast pain, menopausal symptoms, and breast cancer.See details»
HavaH Therapeutics - PitchBook
HavaH Therapeutics General Information Description. Developer of androgen therapies intended for curing breast disease by utilizing the innate breast tissue. The company's therapy delivers a unique androgen product to effect a beneficial tissue-specific alteration in estrogen androgen ratio and reduce breast tissue autoimmune inflammation, providing women with androgenic …See details»
Clarus Therapeutics And HavaH Therapeutics Announce Licensing …
If approved, CLAR-121 would be the first T treatment of its kind for inflammatory breast disease. Tweet this. HavaH has extensive clinical experience with CLAR-121 in more than 1,000 …See details»
Quantum Leap Healthcare Collaborative Initiates Landmark Phase …
Oct 30, 2023 Quantum Leap Healthcare Collaborative is a 501c(3) charitable organization established in 2005 as a collaboration between medical researchers at University of California, …See details»
CLARUS THERAPEUTICS AND HAVAH THERAPEUTICS ANNOUNCE …
2 commercial product, and expands our development pipeline with an initial focus on PDM in women — a debilitating, painful disease with very limited treatment options, short of invasive …See details»
Havah Therapeutics Announces Formation of Clinical Advisory …
Oct 24, 2024 Chaired by founder Stephen Birrell, MD PhD, group includes experts in breast cancer biology, endocrine signaling and biomarker-driven risk reduction strategies BOULDER, …See details»
Quantum Leap Healthcare Collaborative Initiates Landmark Phase …
Oct 30, 2023 Quantum Leap Healthcare Collaborative is a 501c(3) charitable organization established in 2005 as a collaboration between medical researchers at University of California, San Francisco and Silicon ...See details»
Quantum Leap Healthcare Collaborative Initiates Landmark ... - BioSpace
Oct 30, 2023 Quantum Leap Healthcare Collaborative is a 501c(3) charitable organization established in 2005 as a collaboration between medical researchers at University of California, ... More information is available at www.havahtx.com. About The Menarini Group. The Menarini Group is a leading international pharmaceutical and diagnostics company, ...See details»
Havah Therapeutics Pty Ltd.: Drug pipelines, Patents, Clinical trials ...
Explore Havah Therapeutics Pty Ltd. with its drug pipeline, therapeutic area, technology platform, 3 clinical trials, 2 news.See details»
Havah Therapeutics Announces Formation of Clinical Advisory …
Oct 24, 2024 BOULDER, Colo.--(BUSINESS WIRE)--Havah Therapeutics, a clinical stage biopharmaceutical company developing innovative, proprietary hormonal implant therapies for prevention and treatment of breast ...See details»
Quantum Leap Healthcare Collaborative Initiates Landmark Phase …
Quantum Leap Healthcare Collaborative is a 501c(3) charitable organization established in 2005 as a collaboration between medical researchers at University of California, San Francisco and …See details»
Havah Therapeutics Granted Additional Patent Protection for T+Ai™
Nov 14, 2024 Issuance of Patent Protects Claims of T+Ai with Sustained, Multi-Phasic Release Profiles. BOULDER, Colo.--(BUSINESS WIRE)--Havah Therapeutics today, announced that …See details»
Clarus Therapeutics And HavaH Therapeutics Announce Licensing …
May 25, 2021 HavaH has extensive clinical experience with CLAR-121 in more than 1,000 Australian women (more than 6,200 implants) with breast disease, and Clarus expects that …See details»